Smith & Nephew plc (NYSE:SNN) Given Consensus Rating of “Hold” by Analysts

Shares of Smith & Nephew plc (NYSE:SNN) have been assigned an average rating of “Hold” from the five analysts that are covering the company, Marketbeat.com reports. Three analysts have rated the stock with a hold rating and two have issued a buy rating on the company.

Separately, StockNews.com upgraded shares of Smith & Nephew from a “buy” rating to a “strong-buy” rating in a research report on Friday, March 15th.

Smith & Nephew Price Performance

Shares of NYSE:SNN opened at $24.36 on Tuesday. Smith & Nephew has a one year low of $21.52 and a one year high of $33.08. The company has a 50-day simple moving average of $26.26 and a 200-day simple moving average of $25.98. The company has a quick ratio of 0.72, a current ratio of 1.77 and a debt-to-equity ratio of 0.44.

Smith & Nephew Dividend Announcement

The business also recently declared a semi-annual dividend, which will be paid on Wednesday, May 22nd. Shareholders of record on Tuesday, April 2nd will be paid a dividend of $0.462 per share. This represents a yield of 2.8%. The ex-dividend date is Monday, April 1st.

Hedge Funds Weigh In On Smith & Nephew

A number of hedge funds have recently made changes to their positions in the business. Scharf Investments LLC raised its stake in shares of Smith & Nephew by 0.5% in the 1st quarter. Scharf Investments LLC now owns 2,996,264 shares of the medical equipment provider’s stock valued at $75,985,000 after acquiring an additional 15,930 shares during the period. American Century Companies Inc. grew its holdings in Smith & Nephew by 343.5% during the 3rd quarter. American Century Companies Inc. now owns 2,364,037 shares of the medical equipment provider’s stock valued at $58,557,000 after purchasing an additional 1,830,965 shares in the last quarter. Goldman Sachs Group Inc. grew its holdings in Smith & Nephew by 3.4% during the 4th quarter. Goldman Sachs Group Inc. now owns 1,343,712 shares of the medical equipment provider’s stock valued at $36,656,000 after purchasing an additional 44,445 shares in the last quarter. Brandes Investment Partners LP acquired a new stake in Smith & Nephew during the 4th quarter valued at $29,884,000. Finally, Wells Fargo & Company MN grew its holdings in Smith & Nephew by 20.9% during the 4th quarter. Wells Fargo & Company MN now owns 1,003,050 shares of the medical equipment provider’s stock valued at $27,363,000 after purchasing an additional 173,448 shares in the last quarter. Hedge funds and other institutional investors own 25.64% of the company’s stock.

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.